• Home
  • About Us
    • Our Team
    • Remembering Erika
  • Our Current Focus
    • Contraceptive Choices >
      • Be Informed
      • CONTRACEPTIVE CHOICES
      • Things to Know About Contraception
      • CNN Article about Contraceptive Choices
    • Synthetic hormones
    • Video about Blood Clots
    • Video about Deep Vein Thrombosis & Pulmonary Embolisms
    • True Stories >
      • Share Your Story
    • Disinformation >
      • What Drug Reps Don't Tell Doctors
      • Drug Company Dishonesty
      • Drug Safety: Changed By One Little Sentence?
      • What Doctors Don't Know About Drugs
  • Media
    • IN THE MEDIA
    • Vanity Fair - Danger in the Ring
    • Katie Utehs/KTVU.com
    • FDA approved NuvaRing despite experts’ safety concerns
    • Marie Claire Article: Is Your Birth Control as Safe as You Think?
  • References
    • RESEARCH
    • Danish Study: NuvaRing has increased risk
    • FDA-funded Study: Increased risk of VTE with the NuvaRing
    • Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception
  • Donate
    • Donate
  • Our Team
  • About Us

Research

Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception
Excerpt from the study published in the New England Journal of Medicine

In conclusion, women who used oral contraceptives with ethinyl estradiol at a dose of 30 to 40 μg had a risk of arterial thrombosis that was 1.3 to 2.3 times as high as the risk among non- users, and women who used pills with ethinyl estradiol at a dose of 20 μg had a risk that was 0.9 to 1.7 times as high, with only small differences according to progestin type. We estimate that among 10,000 women who use desogestrel with ethinyl estradiol at a dose of 20 μg for 1 year, 2 will have arterial thrombosis and 6.8 women taking the same product will have venous thrombosis. Although venous thrombosis is three to four times as frequent as arterial thrombosis among young women, the latter is associated with higher mortality and more serious consequences for the survivors. Therefore, these figures should be taken into account when prescribing hormonal contraception.

Read the full study by clicking on the link below.
New England Journal of Medicine





IMPORTANT: 
Information shared on this website is intended to
enhance (not replace!) discussions with your doctor and other health care providers.